FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yutaka Tagaya

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Fumi Miyagawa; Keiko Ozato; Yutaka Tagaya; Atsushi Terunuma; Hong Zhang; Stephen I Katz
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.
Noriko Sato; Helen Sabzevari; Song Fu; Wei Ju; Michael N Petrus; Richard N Bamford; Thomas A Waldmann; Yutaka Tagaya
Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα.
Wei Ju; Meili Zhang; Jian-kang Jiang; Craig J Thomas; Unsong Oh; B Bryant; Jing Chen; Noriko Sato; Yutaka Tagaya; John C Morris; John Janik; Steven Jacobson; Thomas A Waldmann
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yutaka Tagaya (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Fumi Miyagawa; Keiko Ozato; Yutaka Tagaya; Atsushi Terunuma; Hong Zhang; Stephen I Katz
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(30):12123-8.
2011: Noriko Sato; Helen Sabzevari; Song Fu; Wei Ju; Michael N Petrus; Richard N Bamford; Thomas A Waldmann; Yutaka Tagaya
Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα.
Blood 2011;117(15):4032-40.
2011: Wei Ju; Meili Zhang; Jian-kang Jiang; Craig J Thomas; Unsong Oh; B Bryant; Jing Chen; Noriko Sato; Yutaka Tagaya; John C Morris; John Janik; Steven Jacobson; Thomas A Waldmann
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Blood 2011;117(6):1938-46.
2010: Yutaka Tagaya
Editorial: memory CD8 T cells now join "Club 21".
Journal of leukocyte biology 2010;87(1):13-5.
2009: Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.
The Journal of experimental medicine 2009;206(6):1219-25.
2008: Marta Catalfamo; Michele Di Mascio; Zonghui Hu; Sharat Srinivasula; Vishakha Thaker; Joseph Adelsberger; Adam Rupert; Michael Baseler; Yutaka Tagaya; Gregg Roby; Catherine Rehm; Dean Follmann; H Clifford Lane
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(50):19851-6.
2008: Fumi Miyagawa; Yutaka Tagaya; Brian S Kim; Hiral J Patel; Kazuto Ishida; Toshiaki Ohteki; Thomas Waldmann; Stephen I Katz
IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(2):1109-19.
2008: Masaki Terabe; Yutaka Tagaya; Qing Zhu; Larry Granger; Mario Roederer; Thomas Waldmann; Jay A Berzofsky
IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(11):7276-86.
2008: M E Christine Lutsiak; Yutaka Tagaya; Anthony J Adams; Jeffrey Schlom; Helen Sabzevari
Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):5871-81.
2007: Sven Mostböck; Marta Catalfamo; Yutaka Tagaya; Jeffrey Schlom; Helen Sabzevari
Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis.
Blood 2007;109(6):2488-95.
2007: Noriko Sato; Hiral J Patel; Thomas Waldmann; Yutaka Tagaya
The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(2):588-93.
2006: Paul A Antony; Chrystal M Paulos; Mojgan Ahmadzadeh; Akgül Akpinarli; Douglas Palmer; Noriko Sato; Andrew Kaiser; Christian S Hinrichs; Christian Heinrichs; Christopher A Klebanoff; Yutaka Tagaya; Nicholas P Restifo
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5255-66.
2005: Hisataka Kobayashi; Satomi Kawamoto; Martin W Brechbiel; Marcelino Bernardo; Noriko Sato; Thomas Waldmann; Yutaka Tagaya; Peter L Choyke
Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle.
Neoplasia (New York, N.Y.) 2005;7(11):984-91.
2005: Fraia Melchionda; Terry J Fry; Matthew J Milliron; Melissa A McKirdy; Yutaka Tagaya; CRYSTAL MACKALL
Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.
The Journal of clinical investigation 2005;115(5):1177-87.
2005: Jun Zhou; Yutaka Tagaya; Roshanak Tolouei-Semnani; Jeffrey Schlom; Helen Sabzevari
Physiological relevance of antigen presentasome (APS), an acquired MHC/costimulatory complex, in the sustained activation of CD4+ T cells in the absence of APCs.
Blood 2005;105(8):3238-46.
2005: Hisataka Kobayashi; Sigrid Dubois; Noriko Sato; Helen Sabzevari; Yoshio Sakai; Thomas Waldmann; Yutaka Tagaya
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.
Blood 2005;105(2):721-7.
2004: Hisataka Kobayashi; Satomi Kawamoto; Yoshio Sakai; Peter L Choyke; robert star; Martin W Brechbiel; Noriko Sato; Yutaka Tagaya; John C Morris; Thomas Waldmann
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.
Journal of the National Cancer Institute 2004;96(9):703-8.
2004: Christopher A Klebanoff; Steven E Finkelstein; Deborah R Surman; Michael K Lichtman; Luca Gattinoni; Marc R Theoret; Navrose Grewal; Paul J Spiess; Paul A Antony; Douglas Palmer; Yutaka Tagaya; STEVEN ROSENBERG; Thomas Waldmann; Nicholas P Restifo
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):1969-74.
2003: Nobuo Yamada; Hironori Matsushima; Yutaka Tagaya; Shinji Shimada; Stephen I Katz
Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells.
The Journal of investigative dermatology 2003;121(6):1425-32.
2003: Hisataka Kobayashi; Satomi Kawamoto; Peter L Choyke; Noriko Sato; Michael V Knopp; robert star; Thomas Waldmann; Yutaka Tagaya; Martin W Brechbiel
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2003;50(4):758-66.
2003: Hisataka Kobayashi; Satomi Kawamoto; robert star; Thomas Waldmann; Yutaka Tagaya; Martin W Brechbiel
Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent.
Cancer research 2003;63(2):271-6.
2002: Sigrid Dubois; Jennifer M Mariner; Thomas Waldmann; Yutaka Tagaya
IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells.
Immunity 2002;17(5):537-47.
2001: Helen Sabzevari; J Kantor; A Jaigirdar; Yutaka Tagaya; M Naramura; J Hodge; J Bernon; Jeffrey Schlom
Acquisition of CD80 (B7-1) by T cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(4):2505-13.
2001: Thomas Waldmann; Sigrid Dubois; Yutaka Tagaya
Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
Immunity 2001;14(2):105-10.
2000: J Marks-Konczalik; Sigrid Dubois; J M Losi; Helen Sabzevari; N Yamada; Lionel Feigenbaum; Thomas Waldmann; Yutaka Tagaya
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(21):11445-50.
2000: G Kurys; Yutaka Tagaya; RN Bamford; John Hanover; Thomas Waldmann
The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15.
The Journal of biological chemistry 2000;275(39):30653-9.
2000: Nazli Azimi; K M Shiramizu; Yutaka Tagaya; Jennifer M Mariner; Thomas Waldmann
Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region.
Journal of virology 2000;74(16):7338-48.
2000: Hisataka Kobayashi; Jorge Carrasquillo; Chang H Paik; Thomas Waldmann; Yutaka Tagaya
Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15.
Cancer research 2000;60(13):3577-83.
1999: H Kobayashi; Yutaka Tagaya; E S Han; I S Kim; N Le; Chang H Paik; Ira Pastan; D L Nelson; Thomas Waldmann; Jorge Carrasquillo
Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Cytokine 1999;11(12):1065-75.
1999: Thomas Waldmann; Yutaka Tagaya
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.
Annual review of immunology 1999;17():19-49.
1998: Nazli Azimi; K Brown; RN Bamford; Yutaka Tagaya; Ulrich Siebenlist; Thomas Waldmann
Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(5):2452-7.
1998: Kouetsu Ogasawara; Shigeaki Hida; Nazli Azimi; Yutaka Tagaya; Toshiro Sato; T Yokochi-Fukuda; Thomas Waldmann; Tadatsugu Taniguchi; Shinsuke Taki
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells.
Nature 1998;391(6668):700-3.
1998: Thomas Waldmann; Yutaka Tagaya; RN Bamford
Interleukin-2, interleukin-15, and their receptors.
International reviews of immunology 1998;16(3-4):205-26.
1997: Yutaka Tagaya; G Kurys; T A Thies; J M Losi; Nazli Azimi; John Hanover; RN Bamford; Thomas Waldmann
Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(26):14444-9.
1996: Yutaka Tagaya; J D Burton; Y Miyamoto; Thomas Waldmann
Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.
The EMBO journal 1996;15(18):4928-39.
1996: Yutaka Tagaya; RN Bamford; A P DeFilippis; Thomas Waldmann
IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.
Immunity 1996;4(4):329-36.
1994: Yutaka Tagaya; Y Maeda; Akira Mitsui; N Kondo; H Matsui; J Hamuro; N Brown; K Arai; T Yokota; H Wakasugi
ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
The EMBO journal 1994;13(9):2244.
1994: H Gomi; Yutaka Tagaya; T Nakano; T Mikayama; KIMISHIGE ISHIZAKA
Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2824-8.
1993: A Mori; P Thomas; Yutaka Tagaya; H Iijima; H Grey; KIMISHIGE ISHIZAKA
Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
International immunology 1993;5(8):833-42.
1993: N Imamura; T Inada; Yutaka Tagaya; J Yodoi; A Kuramoto
Association between ATL and non-hematopoietic neoplasms.
Hematological oncology 1993;11(3):127-37.
1992: H Nakamura; Hiroshi Masutani; Yutaka Tagaya; Akira Yamauchi; Takashi Inamoto; Y Nanbu; Shingo Fujii; K Ozawa; Junji Yodoi
Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma.
Cancer 1992;69(8):2091-7.
1992: K Yamaguchi; A Mori; H Ohno; Yutaka Tagaya; KIMISHIGE ISHIZAKA
Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
International immunology 1992;4(3):337-46.
1992: P Thomas; H Gomi; T Takeuchi; C Carini; Yutaka Tagaya; KIMISHIGE ISHIZAKA
Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(3):729-37.
1992: Akira Yamauchi; Hiroshi Masutani; Yutaka Tagaya; N Wakasugi; Akira Mitsui; H Nakamura; Takashi Inamoto; K Ozawa; Junji Yodoi
Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent.
Molecular immunology 1992;29(2):263-70.
1991: Yutaka Tagaya; A Mori; KIMISHIGE ISHIZAKA
Biochemical characterization of murine glycosylation-inhibiting factor.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(20):9117-21.
1991: Takashi Inamoto; Akira Yamauchi; H Nakamura; Y Nakamura; M Kanai; M Maeda; Yutaka Tagaya; Junji Yodoi; K Ozawa
Hepatocyte growth inhibitory factor derived from HTLV-I(+) T cell lines: effect on the epidermal growth factor-dependent proliferation of rat hepatocytes.
Clinical immunology and immunopathology 1991;58(3):366-76.
1991: S Koyasu; Yutaka Tagaya; K Sugie; S Yonehara; Junji Yodoi; I Yahara
The expression of IL-2R alpha-chain is enhanced by activation of adenylate cyclase in large granular lymphocytes and natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(1):233-8.
1990: Yutaka Tagaya; H Wakasugi; Hiroshi Masutani; H Nakamura; Shingo Iwata; Akira Mitsui; Shingo Fujii; N Wakasugi; Thomas Tursz; Junji Yodoi
Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction.
Molecular immunology 1990;27(12):1279-89.
1990: N Wakasugi; Yutaka Tagaya; H Wakasugi; Akira Mitsui; M Maeda; Junji Yodoi; Thomas Tursz
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(21):8282-6.
1990: T Shindo; K Sugie; K Nakamura; Yutaka Tagaya; M Maeda; Takashi Uchiyama; K Sagawa; M Yokoyama; H Wada; S Hitomi
Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
Immunology 1990;71(1):63-9.
1990: K Sugie; Y Nakamura; Yutaka Tagaya; S Koyasu; I Yahara; K Takakura; S Kumagai; H Imura; Junji Yodoi
70-75 kd molecules expressed on LGL and T cells recognized by a mitogenic monoclonal antibody YTA-1; co-modulation and functional association with the interleukin 2 receptor p75.
International immunology 1990;2(5):391-7.
1989: C Bensimon; N Wakasugi; Yutaka Tagaya; K Takakura; Junji Yodoi; Thomas Tursz; H Wakasugi
Two distinct affinity binding sites for IL-1 on human cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(4):1168-74.
1989: K Takakura; S Taii; M Fukuoka; K Yasuda; Yutaka Tagaya; Junji Yodoi; T Mori
Interleukin-2 receptor/p55(Tac)-inducing activity in porcine follicular fluids.
Endocrinology 1989;125(2):618-23.
1989: H Wakasugi; N Wakasugi; Thomas Tursz; Yutaka Tagaya; Junji Yodoi
Production of an IL-1-like factor by 3B6 EBV-infected B cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(7):2569-70.
1989: Yutaka Tagaya; Y Maeda; Akira Mitsui; N Kondo; H Matsui; J Hamuro; N Brown; K Arai; T Yokota; H Wakasugi
ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
The EMBO journal 1989;8(3):757-64.
1989: Y Nakamura; Takashi Inamoto; K Sugie; Hiroshi Masutani; T Shindo; Yutaka Tagaya; Akira Yamauchi; K Ozawa; Junji Yodoi
Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(4):1318-22.
1988: Hisataka Sabe; A Tanaka; H Siomi; S Koyasu; S Yonehara; I Yahara; Yutaka Tagaya; K Sugie; Keisuke Teshigawara; Junji Yodoi
Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA.
International journal of cancer. Journal international du cancer 1988;41(6):880-5.
1988: Yutaka Tagaya; J Yodoi
[Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-2 and receptor].
Nihon rinsho. Japanese journal of clinical medicine 1988;46(5):1002-7.
1988: Yutaka Tagaya; M Okada; K Sugie; Tadashi Kasahara; N Kondo; J Hamuro; K Matsushima; C A Dinarello; Junji Yodoi
IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2614-20.
1988: Junji Yodoi; Yutaka Tagaya; Hiroshi Masutani; Y Maeda; T Kawabe
IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.
Princess Takamatsu symposia 1988;19():73-86.
1987: H Ishida; S Kumagai; H Umehara; H Sano; Yutaka Tagaya; J Yodoi; H Imura
Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(4):1070-4.
1987: Yutaka Tagaya; Y Taniguchi; M Naramura; M Okada; N Suzuki; H Kanamori; T Nikaido; Tasuku Honjo; Junji Yodoi
Transcription of IL-2 receptor gene is stimulated by ATL-derived factor produced by HTLV-I(+) T cell lines.
Immunology letters 1987;15(3):221-8.
1987: S Narumiya; M Hirata; T Nanba; T Nikaido; Y Taniguchi; Yutaka Tagaya; M Okada; H Mitsuya; J Yodoi
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analogues.
Biochemical and biophysical research communications 1987;143(2):753-60.
1987: K Ikuta; M Takami; C W Kim; T Honjo; T Miyoshi; Yutaka Tagaya; T Kawabe; J Yodoi
Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(3):819-23.
1987: Junji Yodoi; Yutaka Tagaya; M Okada; Y Taniguchi; M Hirata; M Naramura; M Maeda
Interleukin-2 receptor-inducing factor(s) in adult T cell leukemia.
Acta haematologica 1987;78 Suppl 1():56-63.
1987: Junji Yodoi; M Okada; Yutaka Tagaya; Y Taniguchi; Keisuke Teshigawara; Tadashi Kasahara; C A Dinarello; K Matsushima; T Honko; T Uchiyama
IL-2 receptor gene activation by ATL-derived factor (ADF).
Advances in experimental medicine and biology 1987;213():139-48.
1986: K Matsushima; J Yodoi; Yutaka Tagaya; J J Oppenheim
Down-regulation of interleukin 1 (IL 1) receptor expression by IL 1 and fate of internalized 125I-labeled IL 1 beta in a human large granular lymphocyte cell line.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(10):3183-8.
1986: T Noma; T Nakamura; M Maeda; M Okada; Y Taniguchi; Yutaka Tagaya; Y Yaoita; J Yodoi; T Honjo
Interleukin 1 alpha mRNA in virus-transformed T and B cells.
Biochemical and biophysical research communications 1986;139(1):353-60.
1986: S Yamamoto; T Hattori; M Matsuoka; T Ishii; N Asou; M Okada; Yutaka Tagaya; J Yodoi; K Takatsuki
Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cells.
Blood 1986;67(6):1714-20.
1986: S Kondo; A Shimizu; M Maeda; Yutaka Tagaya; J Yodoi; T Honjo
Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection.
Nature 1986;320(6057):75-7.
1986: S Koyasu; J Yodoi; T Nikaido; Yutaka Tagaya; Y Taniguchi; T Honjo; I Yahara
Expression of interleukin 2 receptors on interleukin 3-dependent cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(3):984-7.
1985: M Okada; M Maeda; Yutaka Tagaya; Y Taniguchi; Keisuke Teshigawara; T Yoshiki; T Diamantstein; Kendall A Smith; T Uchiyama; T Honjo
TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(6):3995-4003.
1985: Junji Yodoi; M Okada; Yutaka Tagaya; Keisuke Teshigawara; K Fukui; N Ishida; K Ikuta; M Maeda; T Honjo; H Osawa
Rat lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression of rat interleukin 2 receptor.
The Journal of experimental medicine 1985;161(5):924-34.
1984: Hisataka Sabe; S Kondo; A Shimizu; Yutaka Tagaya; J Yodoi; N Kobayashi; M Hatanaka; N Matsunami; M Maeda; T Noma
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection.
Molecular biology & medicine 1984;2(6):379-96.